Lagis Enterprise Co., Ltd.
Lagis Enterprise Co., Ltd. engages in the manufacturing, processing, and sale of surgical instruments, equipment, and related medical devices Taiwan and China. Its products include trocars, include optical tip trocar, dilating tip trocar, shielded bladed tip trocar, blunt tip trocar, TRE trocar system, balloon trocar; single port surgery devices, include advanced single port device, single port k… Read more
Lagis Enterprise Co., Ltd. (6730) - Net Assets
Latest net assets as of September 2025: NT$604.76 Million TWD
Based on the latest financial reports, Lagis Enterprise Co., Ltd. (6730) has net assets worth NT$604.76 Million TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$1.12 Billion) and total liabilities (NT$517.16 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$604.76 Million |
| % of Total Assets | 53.9% |
| Annual Growth Rate | 3.63% |
| 5-Year Change | 22.87% |
| 10-Year Change | N/A |
| Growth Volatility | 3.98 |
Lagis Enterprise Co., Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how Lagis Enterprise Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lagis Enterprise Co., Ltd. (2019–2024)
The table below shows the annual net assets of Lagis Enterprise Co., Ltd. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$579.80 Million | +7.22% |
| 2023-12-31 | NT$540.77 Million | +1.22% |
| 2022-12-31 | NT$534.26 Million | +7.89% |
| 2021-12-31 | NT$495.18 Million | +4.94% |
| 2020-12-31 | NT$471.86 Million | -2.75% |
| 2019-12-31 | NT$485.19 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lagis Enterprise Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$135.24 Million | 23.32% |
| Common Stock | NT$320.80 Million | 55.33% |
| Other Comprehensive Income | NT$83.33 Million | 14.37% |
| Other Components | NT$40.43 Million | 6.97% |
| Total Equity | NT$579.80 Million | 100.00% |
Lagis Enterprise Co., Ltd. Competitors by Market Cap
The table below lists competitors of Lagis Enterprise Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Asia Green Energy Public Company Limited
BK:AGE
|
$21.00 Million |
|
MCE Holdings Bhd
KLSE:7004
|
$21.01 Million |
|
Tigaraksa Satria Tbk
JK:TGKA
|
$21.01 Million |
|
Shine Justice Ltd
AU:SHJ
|
$21.02 Million |
|
EURODRY LTD. DL -01
F:0LQ
|
$20.99 Million |
|
myNEWS Holdings Bhd
KLSE:5275
|
$20.99 Million |
|
FASOO.COM Co Ltd
KQ:150900
|
$20.98 Million |
|
Fks Multi Agro Tbk
JK:FISH
|
$20.98 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lagis Enterprise Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 540,768,000 to 579,798,000, a change of 39,030,000 (7.2%).
- Net income of 68,236,000 contributed positively to equity growth.
- Dividend payments of 32,001,000 reduced retained earnings.
- New share issuances of 2,695,000 increased equity.
- Other comprehensive income increased equity by 6,511,000.
- Other factors decreased equity by 6,411,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$68.24 Million | +11.77% |
| Dividends Paid | NT$32.00 Million | -5.52% |
| Share Issuances | NT$2.69 Million | +0.46% |
| Other Comprehensive Income | NT$6.51 Million | +1.12% |
| Other Changes | NT$-6.41 Million | -1.11% |
| Total Change | NT$- | 7.22% |
Book Value vs Market Value Analysis
This analysis compares Lagis Enterprise Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.99x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.33x to 1.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | NT$15.46 | NT$36.00 | x |
| 2020-12-31 | NT$14.69 | NT$36.00 | x |
| 2021-12-31 | NT$15.34 | NT$36.00 | x |
| 2022-12-31 | NT$16.41 | NT$36.00 | x |
| 2023-12-31 | NT$16.68 | NT$36.00 | x |
| 2024-12-31 | NT$18.10 | NT$36.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lagis Enterprise Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.77%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.02%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 1.87x
- Recent ROE (11.77%) is below the historical average (12.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 18.38% | 21.93% | 0.69x | 1.21x | NT$40.64 Million |
| 2020 | 6.85% | 10.12% | 0.59x | 1.14x | NT$-14.86 Million |
| 2021 | 9.88% | 12.45% | 0.66x | 1.20x | NT$-581.00K |
| 2022 | 13.30% | 16.06% | 0.67x | 1.23x | NT$17.61 Million |
| 2023 | 11.85% | 13.94% | 0.54x | 1.56x | NT$10.03 Million |
| 2024 | 11.77% | 15.02% | 0.42x | 1.87x | NT$10.26 Million |
Industry Comparison
This section compares Lagis Enterprise Co., Ltd.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,796,147,300
- Average return on equity (ROE) among peers: 10.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lagis Enterprise Co., Ltd. (6730) | NT$604.76 Million | 18.38% | 0.86x | $21.00 Million |
| St.Shine Optical Co Ltd (1565) | $5.39 Billion | 29.48% | 0.60x | $147.19 Million |
| Nang Kuang Pharmaceutical Co Ltd (1752) | $2.19 Billion | 9.94% | 0.50x | $46.91 Million |
| Maxigen Biotech Inc (1783) | $1.14 Billion | 7.68% | 0.11x | $53.63 Million |
| SciVision Biotech Inc (1786) | $1.02 Billion | -2.16% | 0.07x | $107.95 Million |
| Bioteque (4107) | $1.88 Billion | 15.46% | 0.25x | $198.92 Million |
| Chi Sheng Chemical (4111) | $1.22 Billion | 12.60% | 0.47x | $41.85 Million |
| Sunder Biomedical Tech. Co., Ltd. (4115) | $790.45 Million | 1.68% | 0.80x | $2.11K |
| BenQ Medical Technology (4116) | $1.10 Billion | 2.62% | 0.78x | $25.45 Million |
| Pacific Hospital Supply Co Ltd (4126) | $2.26 Billion | 10.49% | 0.61x | $128.74 Million |
| Unicon Optical Co., Ltd. (4150) | $963.23 Million | 21.57% | 0.59x | $22.68 Million |